Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. (Q54276490)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

atopic dermatitis

1 reference

based on heuristic

inferred from title

author name string

C-C E Lan

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

A-H Fang

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

P-H Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

C-S Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

publication date

10 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

28

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

204-215

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

Is eczema really on the increase worldwide?

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Prevalence of adult atopic dermatitis among nursing staff in a Taiwanese medical center: a pilot study on validation of diagnostic questionnaires.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

How cells read TGF-beta signals

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Non-Smad pathways in TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Prevention and management of hypertrophic scars and keloids after burns in children

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Safe treatment of head/neck AD with tacrolimus ointment

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Guidelines for management of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Expression of collagen by renal fibroblasts treated with FK 506 in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

A therapeutic dose of FK506 does not affect collagen turnover pathways in healthy human gingival fibroblasts.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Immunosuppression and gingival overgrowth: gene and protein expression profiles of collagen turnover in FK506-treated human gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

New insights into atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

TGF-beta and fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

TGF-beta signaling and the fibrotic response

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

TGF-β signaling in fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Non-Smad TGF-beta signals

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Pediatric Atopic Dermatitis: A Review of the Medical Management

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12086

21 January 2018

Identifiers

10.1111/JDV.12086

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23301526

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54276490&oldid=1521086969"